Kendra D. Bunner, Ph.D. - Publications

Affiliations: 
2016- Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 

2/10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Carullo NVN, Phillips Iii RA, Simon RC, Soto SAR, Hinds JE, Salisbury AJ, Revanna JS, Bunner KD, Ianov L, Sultan FA, Savell KE, Gersbach CA, Day JJ. Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systems. Nucleic Acids Research. PMID 32810208 DOI: 10.1093/Nar/Gkaa671  0.635
2019 Simon R, Gallus N, Bunner K, Savell K, Sultan F, Day J. Enhancer Rna's In Brain Function and Disease European Neuropsychopharmacology. 29: S773-S774. DOI: 10.1016/J.Euroneuro.2017.06.139  0.313
Low-probability matches (unlikely to be authored by this person)
2016 Bunner KD, Rebec GV. Corticostriatal Dysfunction in Huntington's Disease: The Basics. Frontiers in Human Neuroscience. 10: 317. PMID 27445757 DOI: 10.3389/fnhum.2016.00317  0.254
2014 Estrada-Sánchez AM, Bunner KD, Rebec GV. Huntington's Disease and Dementia: From Transgenic Models to Molecular Neuropathology Diet and Nutrition in Dementia and Cognitive Decline. 77-90. DOI: 10.1016/B978-0-12-407824-6.00008-2  0.221
2022 Rebec GV, Koceja DM, Bunner KD. Measuring movement in health and disease. Brain Research Bulletin. 181: 167-174. PMID 35122899 DOI: 10.1016/j.brainresbull.2022.01.021  0.199
2020 Ponzi A, Barton SJ, Bunner KD, Rangel-Barajas C, Zhang ES, Miller BR, Rebec GV, Kozloski J. Striatal network modeling in Huntington's Disease. Plos Computational Biology. 16: e1007648. PMID 32302302 DOI: 10.1371/journal.pcbi.1007648  0.191
2012 Miller BR, Dorner JL, Bunner KD, Gaither TW, Klein EL, Barton SJ, Rebec GV. Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease. Journal of Neurochemistry. 121: 629-38. PMID 22332910 DOI: 10.1111/J.1471-4159.2012.07691.X  0.12
2016 Covey DP, Bunner KD, Schuweiler DR, Cheer JF, Garris PA. Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. The European Journal of Neuroscience. PMID 27038339 DOI: 10.1111/ejn.13248  0.117
2022 Oliva I, Saberi SA, Rangel-Barajas C, Iyer V, Bunner KD, Lai YY, Kulkarni PM, Garai S, Thakur GA, Crystal JD, Rebec GV, Hohmann AG. Inhibition of PSD95-nNOS protein-protein interactions decreases morphine reward and relapse vulnerability in rats. Addiction Biology. 27: e13220. PMID 36001441 DOI: 10.1111/adb.13220  0.113
2013 Daberkow DP, Brown HD, Bunner KD, Kraniotis SA, Doellman MA, Ragozzino ME, Garris PA, Roitman MF. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 452-63. PMID 23303926 DOI: 10.1523/Jneurosci.2136-12.2013  0.063
Hide low-probability matches.